Related Experiment Video

Updated: Jul 13, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Searching for novel therapeutics and targets: insights from clinical trials

Anirban P Mitra1, Richard J Cote

  • 1Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA.

Urologic Oncology
|July 14, 2007
PubMed

Insights

Recent bladder cancer research identifies new molecular targets for drug development. Effective treatments will likely combine agents targeting multiple pathways, transforming patient management through novel clinical trials.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Advances in understanding bladder cancer molecular mechanisms are crucial.
  • Identification of molecular targets is key for novel therapeutic agents.
  • Current understanding suggests combination therapies are necessary for effective bladder cancer treatment.

Purpose of the Study:

  • To highlight recent molecular insights into bladder tumorigenesis.
  • To emphasize the need for multi-targeted therapeutic strategies.
  • To discuss the future transformation of bladder cancer management.

Main Methods:

  • Review of recent scientific literature on bladder cancer molecular mechanisms.
  • Analysis of current therapeutic strategies for superficial and invasive bladder cancers.
  • Discussion of the translation of molecular understanding into clinical practice.

Main Results:

  • Identification of novel molecular targets for bladder cancer therapy.
  • Recognition of the importance of combination therapies targeting multiple tumorigenic pathways.
  • Anticipation of significant changes in bladder cancer patient management.

Conclusions:

  • Molecular understanding is driving the development of new bladder cancer therapies.
  • Combination therapeutic agents targeting multiple pathways are essential.
  • Future bladder cancer management will be revolutionized by translating molecular insights into clinical trials and screening.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...